VIVO - Meridian Bioscience, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue9/30/20169/30/20159/30/2014
Total Revenue196,082194,830188,832
Cost of Revenue68,29572,94871,589
Gross Profit127,787121,882117,243
Operating Expenses
Research Development13,81512,60512,552
Selling General and Administrative61,11353,21752,299
Non Recurring1,4811,4811,481
Others---
Total Operating Expenses---
Operating Income or Loss51,37856,06052,392
Income from Continuing Operations
Total Other Income/Expenses Net163-997-284
Earnings Before Interest and Taxes51,54155,06352,108
Interest Expense897897897
Income Before Tax50,64455,06352,108
Income Tax Expense18,41519,52317,365
Minority Interest---
Net Income From Continuing Ops32,22935,54034,743
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income32,22935,54034,743
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares32,22935,54034,743